InterHealth Presents Research at Conferences

InterHealth Presents Research at Conferences

BENECIA, Calif.InterHealthNutraceuticals Inc. unveiled new research surrounding its products at threescientific conferences: the 42nd Congress of European Societies of Toxicology(EuroTox 2005), the 46th Annual Meeting of the American College of Nutrition(ACN), and the 6th International Conference of the Society for Free RadicalResearch (SFRR).

New research presented by the company included a safety andefficacy study conducted on a new proprietary energy formula; a comprehensiveoverview of research on the safety of the companys patented, niacin-boundchromium product (ChromeMate®); a clinical trial showing the combination ofundenatured type II collagen (as UC-II®), glucosamine and chondroitin reducedpain and lameness in dogs with osteoarthritis; and an overview of research onthe companys antioxidant and anti-angiogenic multiple berry extract(OptiBerry®). In addition, Debasis Bagchi, Ph.D., vice president of researchand development for InterHealth, chaired a symposium on how changes in nutritionand lifestyle can prevent sarcopenia and fat gain associated with advancing age,and a group of InterHealth researchers participated in a session onmicronutrients as they relate to human health and disease.

InterHealths participation in these esteemed globalscientific conferences is representative of our steadfast commitment andcontinuing investment in research as the foundation for each of our value-added,proprietary ingredients, said William Skip Seroy, president and chief executiveofficer (CEO) of the company.

For more information, visit www.interhealthusa.com or Booth#5015 at SupplySide West.